AnPac Bio: Jumps on joint venture to develop novel cancer treatment tech

Fresh2

25/05/2021 12:39

** Shares of biotech co  ANPC.O  rise 29.2% to $6 premarket
    ** Co says its board on May 17 approved establishing a joint
venture with founder and chairman Chris Chang Yu to develop a
new cancer treatment technology  urn:newsml:reuters.com:*:nGNXlSzrJ
    ** Co will contribute two filed patent applications in
cancer treatment to the joint venture
    ** Says the new cancer treatment tech to be developed by the
venture expected to be based on AnPac's findings in the past 10
years of early-stage cancer detection work involving 222,200
samples, among other things
    ** The aim of the technology is to prevent disease
progression for both pre-cancer and cancer patients, and
laboratory tests on it expected to begin in Q3 2021 - ANPC
    ** Up to last close, ANPC stock down 11.7% YTD

 (Reporting by Vishwadha Chander in Bengaluru)
 ((Vishwadha.Chander@thomsonreuters.com;))